Benralizumab
Also known as Fasenra (us)
Benralizumab injection is used along with other medications to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in adults and children 6 years and older whose asthma is not controlled with their current asthma medication.
Based on 30 units per month. US $5,669.65 vs India $2,205.31 per unit.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $623,581
- Estimated travel cost
- − $2,300
- Net savings after travel
- $621,281
Even after travel, you could come out ahead by about $621,281.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Benralizumab is filled about 53.8K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.